VALNEVA
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-03-18
Samuel Tiven
Analyst
Guggenheim
Equibles does not estimate personal net worth.
About Samuel Tiven
Samuel Tiven is recorded as Analyst at Guggenheim. Samuel Tiven has spoken on 1 earnings call across 1 company, most recently for VALNEVA on March 18, 2026. The companies whose calls Samuel Tiven spoke on are classified in the Healthcare sector.
Samuel Tiven on recent calls
“So two, I could, one back on Lyme and then one other topic. So on the Lyme, I appreciate everything you said around here, Pfizer, running the trial Just curious if you know what actually would be in the top-line press release.”
Affiliation history
-
Guggenheim
Analyst
Transcript header (unverified)
Current
Company network
Recent activity
-
Earnings call
FY 2025 Financial Results
VALNEVA